Close Menu

stock offering

NEW YORK (GenomeWeb News) – Accelerate Diagnostics has filed a shelf registration to publicly offer from time to time up to $150 million of securities.

Tekmira Pharmaceuticals this week announced that it has completed the public offering of $30 million of its common stock.

NEW YORK (GenomeWeb News) – Venaxis, which is developing a multi-biomarker test for appendicitis, filed a shelf registration to publicly offer up to $20 million of its stock.

NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market last night that it had priced its offering of 2,858,000 shares of common stock at $14 per share.

NEW YORK (GenomeWeb News) – Cancer Genetics today increased the proposed amount it is seeking to raise from a public offering of its common stock.

NEW YORK (GenomeWeb News) – Cancer Genetics has filed to raise up to $46 million in a public offering of its stock.

NEW YORK (GenomeWeb News) – Response Genetics today said that it has signed definitive agreements with unnamed institutional investors for the sale of 932,805 shares of the firm's common stock through a registered direct offering.

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of common stock that has raised net proceeds of around $27.7 million.

NEW YORK (GenomeWeb News) – Nanosphere said Friday that it will offer 15 million shares of its common stock in a public offering priced at $1.75 per share.

NEW YORK (GenomeWeb News) – Cancer Genetics today said that the underwriters for its recent public offering have partially exercised an overallotment option, purchasing an additional 105,000 shares at $10 per share.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.